1. Magomedova B. M., Glebov K. G., Teplova N. V., Kotovsky A. E., Artamonova N. G. Changes in the mucose of upper gastrointestinal tract in coronary heart disease. Cardiovascular Th erapy and Prevention. 2017;16(6):65– 69. (In Russ.) https://doi.org/10.15829/1728-8800-2017- 6-65-69
2. Iskakov B. S., Umenova G. Zh., Shepshelevich Yu. V. et al. An algorithm for diagnosing gastroduodenal pathology in patients with coronary heart disease. Bulletin of KazNMU. 2017. No. 1.
3. Huang K.W., Luo J. C., Leu H. B. et al. Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel//J Chin Med Assoc. 2013 Jan;76(1):9–14.
4. Vertkin A. L., Frolova Yu. V., Petrik E. A. et al. Prevention of gastrointestinal bleeding with exacerbation of coronary heart disease. Consilium medicum. Gastroenterology. 2008; (2): 3-5
5. Ivashkin V. T., Sheptulinn A. A. Maev I. V. et al. Clinical recommendations of the Russian Gastroenterological Association for the diagnosis and treatment of erosive and ulcerative lesions of the stomach caused by the use of non-steroidal anti-inflammatory drugs. RZHGKP. 2014; 6: 89–94.